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A B S T R A C T
The aim of this study was to assess colonisation and transmission of third-generation cephalosporin-
resistant Enterobacteriaceae (CRE) from patients in 16 intensive care units. A prospective, repetitive
point prevalence survey was performed over 6 months, involving samples from 1851 patients. CRE were
isolated from 186 (10%) patients, with Enterobacter spp. being the most common. Mean point prevalence
rates were significantly higher for paediatric wards (22.5%) compared to surgical (8.1%) and medical
(5.5%) units. All CRE isolates were typed by pulsed-field gel electrophoresis. Non-outbreak nosocomial
transmission rates of these pathogens were calculated as 12.8% for paediatric patients, compared to
6.8% for adult patients, which may reflect differences in sensitivity to overgrowth with resistant bacteria
and contact with health care workers.
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I N T R O D U C T I O N
Isolation of third-generation cephalosporin-resist-
ant Enterobacteriaceae (CRE) has been reported
with increasing frequency for some years, often
involving outbreaks in neonatal intensive care
units (ICUs) [1–3]. Information about the preval-
ence of CRE in non-outbreak situations or other
patient populations is limited, and is usually
restricted to one or two specific ICUs [4,5]. The
aim of this study was to investigate the preval-
ence of CRE colonisation in patients of all 16 ICUs
of Heidelberg University Hospitals, and to assess
the frequency of nosocomial transmission during
ICU stay.
P A T I E N T S A N D M E T H O D S
Study design and setting
A prospective, repetitive point prevalence study was con-
ducted over a 26-week period, starting in October 2000.
Demographic and clinical data were obtained using a
questionnaire. The severity of illness was assessed by the
McCabe Jackson score [6]. The study was conducted at
Heidelberg University Hospitals, a 1600-bed tertiary care
facility with c. 60 000 admissions annually. All 16 ICUs
participated, including three paediatric ICUs (neonatology
(NICU), paediatric cardiology, general paediatrics), eight
surgical ICUs (cardiac surgery, general surgery, transplanta-
tion surgery, urology, neurosurgery, orthopaedic surgery,
gynaecology, thoracic surgery), one ICU with surgical (ear,
nose and throat, and orthodontic surgery) and medical
(neurological) patients, and four medical ICUs (cardio–pul-
monary, gastrointestinal, stroke unit, haematology and bone
marrow transplants). In these 16 ICUs, a minimum of six and
a maximum of 16 beds were provided. Single bedrooms were
available in 50% of the ICUs. Four of the ICUs did not treat
mechanically ventilated patients.
Microbiological investigation
Peri-rectal swabs were taken weekly from all patients present
on the ICU. All swabs were collected using a commercially
available transport system (Trans-swabTM; Mast, Reinfeld,
Germany) and plated on sheep blood 5% agar and MacConkey
agar.
For all aerobic Gram-negative organisms, susceptibility
testing for cefpodoxime and ceftazidime was performed by
agar disk diffusion tests on Mueller–Hinton agar. All isolates
with a zone diameter of < 22 mm for one of the antibiotics of
interest (according to NCCLS2 criteria [7] for screening for3
enterobacteria producing extended-spectrum b-lactamases
(ESBLs)) were identified to the species level by standard
microbiological procedures (phenotypic characteristics, oxid-
ase reaction) and a commercial microidentification system
Corresponding author and reprint requests: H. von Baum,
Infection Control, Institute of Medical Microbiology and
Hygiene, Ulm University, Steinho¨velstr.9, 89077 Ulm,
Germany
E-mail: heike.von-baum@medizin.uni-ulm.de
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
(API 20E and API 20:NE; bioMe´rieux, Marcy-l’Etoile, France).
In addition, Etests (AB Biodisk, Solna, Sweden) were per-
formed to determine the MICs of ceftazidime and cefpodoxime.
Isolates resistant to ceftazidime (MIC ‡ 32 mg ⁄L) and cefpo-
doxime (MIC ‡ 8 mg ⁄L) were defined as CRE. The first isolate
of each species ⁄patient that was resistant to both third-
generation cephalosporins was characterised genotypically
by pulsed-field gel electrophoresis (PFGE) after digestion with
the restriction enzyme SpeI [8].
Data analysis
The point prevalence rate was calculated for each unit on each
day of investigation. The means of the weekly point preva-
lences were used to compare different units. An analysis of
variance (ANOVA) was performed to investigate significant
differences among the studied ICUs. Post-hoc analysis was
performed by the Bonferroni method. All tests were performed
two-tailed.
Two investigators compared the banding patterns resulting
from PFGE independently. The criteria of Tenover et al. [9]
were used for interpretation, with the modification that isolates
were considered to be different strains if < 90% of the bands
matched (>3 bands different). If two patients carried a
genotypically identical strain, this was considered as one
transmission event. The transmission rate was calculated as the
number of transmission events divided by 100 carriers of CRE.
R E S U L T S
During the study period, c. 5200 patients were
admitted to the 16 ICUs. All patients present on
one of the days of investigation were included in
the study (n ¼ 1851). Eighty-four (4.5%) study
patients were admitted to more than one ICU
during the study period. The study population
was very heterogeneous and included neonates as
well as nonagenarians. The proportion of patients
with a McCabe–Jackson score of one, signifying a
very poor prognosis, varied from 1% for the
NICU to 45% for the neurological ICU. In the
NICU and two medical ICUs, no patient had
undergone a surgical procedure. The percentage
of participants who had already received antibi-
otics when their first swab was taken varied from
15.9% to 81.8%, according to ICU. The antibiotics
used most commonly were cephalosporins and
penicillin + b-lactamase-inhibitor combinations
(Table 1).
Peri-rectal swabs (n ¼ 3353) were obtained
from the study patients (mean ¼ 1.8 swabs ⁄
patient). CRE were isolated from 328 (10%) swabs
from 186 patients. Enterobacter spp. (71%), partic-
ularly Enterobacter cloacae, and Citrobacter spp.
(20%) accounted for most resistant isolates. The
species distribution of the isolates is presented in
Table 2. Six patients carried eight ESBL-positive
enterobacteria. The mean length of observation
before the first CRE-positive swab was 23.3 days,
compared to 12.9 days before discharge from the
ICU for CRE-negative patients.
The weekly point prevalence rates varied
considerably for each unit. Rates for three
representative wards are presented in Fig. 1.
The NICU had consistently high prevalence
rates at the beginning of the investigation. An
ongoing outbreak was suspected and interven-
tional measures were initiated; this unit was
therefore excluded from further analysis. The
mean weekly point prevalence rates for the
remaining 15 ICUs ranged from 1.3% on a
medical ICU to 22.9% on a paediatric ICU
(Fig. 2.). It was of interest that the prevalence
rates in paediatric wards were significantly
higher than in surgical or medical wards
(p < 0.001). Although the prevalence rates were
higher in surgical wards compared to medical
wards, this difference did not reach statistical
significance (p 0.087)
Isolates (n ¼ 189) from 186 patients carrying
CRE were typed by PFGE. Fourteen isolates
(7.5%) were not viable or typable. Three
patients carried more than one CRE. The sus-
pected outbreak in the NICU was confirmed by
the finding that 15 of 17 neonates carried an
identical E. cloacae strain, accounting for a trans-
mission rate of 88%. In the two paediatric ICUs,
two PFGE clusters were delineated. Four paedi-
atric patients were colonised with an identical
E. cloacae strain, whereas six paediatric patients
carried an identical Enterobacter agglomerans
strain. In the 13 remaining non-paediatric ICUs,
two patients each shared nine distinct Enterob-
acter strains. Thus, the transmission rate for
children in a non-outbreak situation was 12.8%,
compared to a transmission rate of 6.8% for
adult patients.
In a hypothetical model, the prevalence rates
for the two paediatric ICUs were calculated,
excluding the patients for whom a nosocomial
transmission was assumed. Nevertheless, the
prevalence rates for these wards were higher
(18.9 and 16.5) than for the non-paediatric wards.
Of the colonised patients, 10% developed an
infection with a CRE as the causative organism.
Most of these patients had pneumonia, and
septicaemia occurred in one patient.
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D I S C U S S I O N
The occurrence of CRE has been reported for
decades. Many authors have investigated out-
breaks caused by ESBL-positive Klebsiella spp. or
highly resistant Enterobacter spp. harbouring the
ampC resistance gene [2,5,10,11]. However, data
concerning the prevalence of CRE in a non-
outbreak setting are limited. To our knowledge,
this study is the first investigation describing the
prevalence of CRE on 16 different ICUs simulta-
neously. Over a 26-week period, weekly point
prevalence rates were consistently highest on the
paediatric wards. Even when excluding children
with an assumed nosocomial transmission of CRE
from the calculation, the point prevalence rates on
the paediatric wards remained higher than on the
non-paediatric units.
Table 1. Basic characteristics of the participating ICUs and the study population
ICU
No. of
beds
No. of
respirators
No. of
single
rooms
No. of
study
patients
Mean
age (range)
of study patients
Rate of study
patients
with surgery
Rate of study
patients with
Study patients
1st visit (%)
Predominant antibiotic therapy
in study patients with AB
MC 1 MC 2 MC 3 1st choice 2nd choice
NICU 11 11 0 118 5 days
(1–49 days)
0 1% 5% 94%
P 2 12 12 2 90 2.8 years
(1 day)17.8 years)
17.2% 10% 21% 69% 56.6 Ceph II + III
P 1 12 9 0 86 2.5 years
(1 day)18 years)
62.6% 3% 21% 76% 65.7 Ceph II + III
S 2 12 12 0 144 63.4 years
(4–95),
82.3% 25% 41% 34% 63.3 Ceph II + III Metronidazole
S 4 6 6 4 74 58.5 years
(17–92)
83.8% 30% 47% 23% 63.5 Ceph II + III
S 5 10 4 2 109 58.8 years
(6–92)
96.3% 13% 29% 58% 40.7 Ceph II
S 1 16 16 0 164 68.8 years
(7–87 years)
95.9% 2% 58% 40% 69.8 Quinolones Ceph II + III
M 1 10 4 4 169 66.4 years
(23–93)
4.6% 30% 44% 26% 51.4 Pen+b-lactam inhibitor
M ⁄ S 10 10 2 109 62.4 years
(31–90)
37.4% 45% 38% 17% 67 Pen+b-lactam inhibitor
M 2 14 6 4 139 58.7 years
(20–89)
7.7% 38% 40% 22% 81.8 Pen+b-lactam inhibitor Macrolides
S 8 12 12 0 169 59.2 years
(16–86)
76.9% 20% 57% 23% 33 Pen+b-lactam inhibitor
S 7 8 0 1 80 47.6 years
(24–78)
91.3% 6% 20% 74% 43.8 Ceph II Metronidazole
S 6 12 12 0 102 56 years
(12–81)
91.3% 28% 33% 39% 52.4 Ceph II + III Pen+b-lactam
inhibitor
M 3 16 0 0 251 62.2 years
(19–90)
0 3% 31% 66% 15.9 Pen+b-lactam inhibitor
S 3 8 0 0 88 57.1 years
(17–87)
88.5% 5% 54% 41% 74 Ceph II + III Co-trimoxazole
M 4 10 0 6 62 50.3 years
(21–76)
0 19% 66% 15% 75.3 Co-trimoxazole Quinolones
AB, antibiotics; Ceph, Cephalosporins; Pen, Penicillin, MC, McCabe–Jackson score; P, Paediatric ICU; S, Surgical ICU; M, Medical ICU.
Table 2. Species distribution of isolates resistant to third-
generation cephalosporins
Species % of CRE Isolates
Enterobacter cloacae 53
Citrobacter freundii 19.7
Enterobacter sakazakii 6.6
Enterobacter aerogenes 5.5
Enterobacter agglomerans 4.9
Morganella morganii 3.3
Escherichia coli 1.6
Hafnia alvei 1.6
Klebsiella pneumoniae 1.6
Citrobacter amalonaticus 0.55
Enterobacter amnigenus 0.55
Proteus vulgaris 0.55
Serratia liquefaciens 0.55
0
10
20
30%
40
50
60
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
SURG
MED
PED
Fig. 1. Weekly point prevalence rates of colonisation with
Enterobacteriaceae resistant to third-generation cephalos-
porins for three representative ICUs (paediatric, surgical
and medical unit).
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Some theories on the mechanisms of nosoco-
mial spread of CRE during a non-outbreak period
have been formulated. Patients may acquire CRE
endogenously or exogenously. Some authors have
demonstrated that patients were colonised with
susceptible Enterobacteriaceae that developed
resistance whilst undergoing extensive antibiotic
treatment [12,13]. Others observed that patients
were already colonised with CRE on admission to
the ICU. Antibiotic treatment favoured over-
growth of the resistant strains in the gastrointes-
tinal tract, thereby selecting colonising strains
from the patients’ own gut flora [4,14,15]. The
present study provided no data to differentiate
between these two modes of colonisation. How-
ever, the sporadic transmission rates in the adult
patient population support the theory that, at
least in adult ICU patients, most CRE are acquired
before admission to the ICU and that transmission
is a rare event. Other authors have reported
similar observations [15,16]. D’Agata et al. found a
transmission rate of only 3% on surgical ICUs
[4,17]. It can be concluded that horizontal trans-
mission between adult ICU patients in a non-
outbreak period is an unusual occurrence.
In contrast, children, and especially neonates,
are prone to acquire CRE via patient-to-patient
transmission. It has been reported that the gut of
young children is especially sensitive to over-
growth with resistant bacteria [18–20]. A very
young patient is therefore at higher risk of
acquiring a multiresistant organism if these bac-
teria are present in sufficient frequency in the
environment. It has been demonstrated that
Enterobacteriaceae can survive in the inanimate
environment [21] and can be recovered frequently
from the hands of health care workers [2,3].
The impact of cephalosporin therapy on the
development of cephalosporin-resistant Entero-
bacteriaceae has been discussed widely, although
caution is required in drawing conclusions from
ecological studies. It is worth noting that, in the
present study, most patients in ICUs with weekly
median point prevalence rates of >9% had
received cephalosporins as a first-line therapy.
A two-fold preventative approach for limiting
the spread of CRE in ICUs should be initiated,
and can prove successful. De Man et al. [22]
showed the positive impact of narrow-spectrum
antibiotics as a first-line therapy in neonatal
septicaemia. It was possible to reduce the pro-
portion of resistant colonising Gram-negative
flora by choosing antibiotics with less selective
pressure on the mucosal environment [22]. Con-
sidering that the use of third-generation cephalo-
sporins has been suggested as a risk factor for
subsequent colonisation and ⁄ or infection with
CRE, restricting the use of these substances for
any environment with a high prevalence of these
organisms should be discussed. The second
approach involves the strict implementation of
basic infection control practices, such as appro-
priate hand hygiene and control of environmental
sources, especially in the care of neonates or
young children.
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